SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-293726
Filing Date
2023-12-13
Accepted
2023-12-12 21:52:05
Documents
12
Period of Report
2023-12-12
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d37178d8k.htm   iXBRL 8-K 27688
  Complete submission text file 0001193125-23-293726.txt   150425

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bxrx-20231212.xsd EX-101.SCH 2503
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bxrx-20231212_lab.xml EX-101.LAB 17947
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bxrx-20231212_pre.xml EX-101.PRE 11230
6 EXTRACTED XBRL INSTANCE DOCUMENT d37178d8k_htm.xml XML 3598
Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 484-395-2470
Baudax Bio, Inc. (Filer) CIK: 0001780097 (see all company filings)

IRS No.: 474639500 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39101 | Film No.: 231482845
SIC: 2834 Pharmaceutical Preparations